AVSF - Precision Neuroscience 2022, LLC is a venture capital fund based in Boston, Massachusetts. According to its most recent Form D, filed Jan 20, 2023, it has sold $2,303,347 of interests to 193 investors since its first sale in Jan 2023. The minimum investment it accepts from an outside investor is $5,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Michael Collins.
- Total raised
- $2,303,347Cumulative sales reported on Form D
- Investors
- 193
- First sale
- Jan 6, 2023
- Minimum investment
- $5,000
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Michael Collins
- Latest Form D
- Jan 20, 2023
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about AVSF - Precision Neuroscience 2022, LLC
What is the minimum investment for AVSF - Precision Neuroscience 2022, LLC?
According to its latest Form D, filed Jan 20, 2023, the minimum investment AVSF - Precision Neuroscience 2022, LLC accepts from an outside investor is $5,000.
Who can invest in AVSF - Precision Neuroscience 2022, LLC?
AVSF - Precision Neuroscience 2022, LLC is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has AVSF - Precision Neuroscience 2022, LLC raised?
AVSF - Precision Neuroscience 2022, LLC reports $2,303,347 sold from 193 investors on its Form D filed Jan 20, 2023. This is cumulative sales since the offering began, not current assets or performance.
Where is AVSF - Precision Neuroscience 2022, LLC based?
AVSF - Precision Neuroscience 2022, LLC is based in Boston, Massachusetts.
When did AVSF - Precision Neuroscience 2022, LLC launch?
AVSF - Precision Neuroscience 2022, LLC reports its first sale in Jan 2023.
Size compared with every venture capital fund
Raised more than 73% of the 533 venture capital funds based in Massachusetts, and more than 73% of all 14,876 that report sales.